<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-10-28">28 October 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">F</forename><surname>Estelle</surname></persName>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Simons</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatrics &amp; Child Health and Department of Immunology</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">College of Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution">The University of Manitoba</orgName>
								<address>
									<addrLine>Room FE125, 820 Sherbrook Street</addrLine>
									<postCode>R3A 1R9 MB</postCode>
									<settlement>Winnipeg</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Pediatrics &amp; Child Health and Department of Immunology</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">College of Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Health Sciences</orgName>
								<orgName type="institution">The University of Manitoba</orgName>
								<address>
									<addrLine>Room FE125, 820 Sherbrook Street</addrLine>
									<postCode>R3A 1R9 MB</postCode>
									<settlement>Winnipeg</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Motohiro</forename><surname>Ebisawa</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Allergy</orgName>
								<orgName type="department" key="dep2">Clinical Research Center for Allergy &amp; Rheumatology</orgName>
								<orgName type="institution">Sagamihara National Hospital</orgName>
								<address>
									<settlement>Sagamihara</settlement>
									<region>Kanagawa</region>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mario</forename><surname>Sanchez-Borges</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Allergy and Clinical Immunology Department</orgName>
								<address>
									<addrLine>Centro Medico-Docente La Trinidad</addrLine>
									<settlement>Caracas</settlement>
									<country key="VE">Venezuela</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bernard</forename><forename type="middle">Y</forename><surname>Thong</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Rheumatology, Allergy &amp; Immunology</orgName>
								<orgName type="institution">Tan Tock Seng Hospital</orgName>
								<address>
									<settlement>Singapore</settlement>
									<country key="SG">Singapore</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Margitta</forename><surname>Worm</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Klinik fur Dermatologie</orgName>
								<orgName type="institution">Allergie-Centrum-Charite</orgName>
								<address>
									<addrLine>Venerologie und Allergologie, Campus Charite Mitte</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">Universitatsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luciana</forename><forename type="middle">Kase</forename><surname>Tanno</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Allergy and Clinical Immunology</orgName>
								<orgName type="institution">Hospital Servidor Publico Estadual de Sao Paulo and Hospital Sirio-Libanes</orgName>
								<address>
									<settlement>Sao Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Richard</forename><forename type="middle">F</forename><surname>Lockey</surname></persName>
							<affiliation key="aff10">
								<orgName type="institution">University of South Florida College of Medicine</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yehia</forename><forename type="middle">M</forename><surname>El-Gamal</surname></persName>
							<affiliation key="aff11">
								<orgName type="laboratory">Pediatric Allergy and Immunology Unit</orgName>
								<orgName type="institution" key="instit1">Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Ain Shams University</orgName>
								<address>
									<settlement>Cairo</settlement>
									<country key="EG">Egypt</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><surname>Ga Brown</surname></persName>
							<affiliation key="aff12">
								<orgName type="institution" key="instit1">Royal Hobart Hospital</orgName>
								<orgName type="institution" key="instit2">University of Western Australia and Royal Perth Hospital</orgName>
								<address>
									<settlement>Perth</settlement>
									<region>Tasmania, Western Australia</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hae-Sim</forename><surname>Park</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Allergy &amp; Clinical Immunology</orgName>
								<orgName type="institution">Ajou University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country>South Korea. 11 Allergy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Aziz</forename><surname>Sheikh</surname></persName>
						</author>
						<author>
							<persName><roleName>Prof. F</roleName><forename type="middle">E R</forename><surname>Simons</surname></persName>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="laboratory">Respiratory Research Group</orgName>
								<orgName type="institution" key="instit1">Usher Institute of Population Health Sciences and Informatics</orgName>
								<orgName type="institution" key="instit2">The University of Edinburgh</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-10-28">28 October 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">3A8AE3798799D1E207A0F0D0F4011DD4</idno>
					<idno type="DOI">10.1186/s40413-015-0080-1</idno>
					<note type="submission">Received: 6 August 2015 Accepted: 25 September 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:43+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Anaphylaxis</term>
					<term>Epinephrine</term>
					<term>Auto-injector</term>
					<term>Food allergy</term>
					<term>Stinging insect venom allergy</term>
					<term>Drug allergy</term>
					<term>Latex allergy</term>
					<term>Exercise-induced anaphylaxis</term>
					<term>Systemic allergic reaction</term>
					<term>Adrenaline</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease.</s><s>Recommendations made in the original WAO Anaphylaxis Guidelines remain clinically valid and relevant, and are a widely accessed and frequently cited resource.</s><s>In this 2015 update of the evidence supporting recommendations in the Guidelines, new information based on anaphylaxis publications from January 2014 through mid-2015 is summarized.</s><s>Advances in epidemiology, diagnosis, and management in healthcare and community settings are highlighted.</s><s>Additionally, new information about patient factors that increase the risk of severe and/or fatal anaphylaxis and patient co-factors that amplify anaphylactic episodes is presented and new information about anaphylaxis triggers and confirmation of triggers to facilitate specific trigger avoidance and immunomodulation is reviewed.</s><s>The update includes tables summarizing important advances in anaphylaxis research.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The World Allergy Organization (WAO) Guidelines for the Assessment and Management of Anaphylaxis remain a clinically relevant, widely accessed, and frequently cited resource <ref type="bibr" target="#b0">[1]</ref>.</s><s>This 2015 Update is intended for use in conjunction with these WAO Anaphylaxis Guidelines, the 2012 and 2013 Updates of the evidence supporting the Guidelines, and the 2014 International Consensus on (ICON): Anaphylaxis, a publication with a broader mandate than the Updates <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref>.</s></p><p><s>Here, we review research published in peer-reviewed indexed journals from January 2014 through mid-2015 on the epidemiology of anaphylaxis, patient risk factors, amplifying co-factors, triggers, diagnosis, and management in healthcare and community settings.</s><s>We also highlight excellence in clinical and translational research relevant to anaphylaxis and cite major publications from other allergy/immunology professional organizations <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref> and different global regions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Epidemiology</head><p><s>Updated information about the epidemiology of anaphylaxis, a life-threatening systemic or hypersensitivity reaction with sudden onset, comes from general population surveys and secondary analyses of large clinical and administrative databases <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> (Table <ref type="table">1</ref>).</s></p><p><s>The lifetime risk of symptoms suggestive of anaphylaxis in the general population, as reported by members of the public, is at least 1.6 %.</s><s>This estimate is based on a survey of 1000 unselected US adults with a suddenonset illness involving two or more body organ systems, including the respiratory and/or cardiovascular systems, who sensed their lives were in danger and received hospital care <ref type="bibr" target="#b7">[8]</ref>.</s></p><p><s>The frequency of hospital admissions for anaphylaxis is increasing.</s><s>Information obtained from the US Healthcare Cost and Utilization Project Kids' In-Patient Database consisting of a stratified random sample of 12,039,432 hospital discharges indicated that admissions for food-induced anaphylaxis in children aged &lt;18 years more than doubled from 2000 to 2009, with corresponding increases in associated healthcare costs <ref type="bibr" target="#b8">[9]</ref>.</s><s>Similarly, analysis of the Italian Ministry of Health database revealed that hospitalizations for food-induced anaphylaxis in children increased year-on-year from 2006 through 2011.</s><s>The increase was more pronounced in those aged 5-14 years than in those age 4 years or younger <ref type="bibr" target="#b9">[10]</ref>.</s><s>Time trends in Australian hospitalization rates for food-induced anaphylaxis indicate that admissions continue to increase across all age groups.</s><s>Although the highest hospitalization rates occurred in children age 0-4 years, the greatest acceleration in the rates of increase was found in the age groups 5-14 years and 15-29 years <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>In England and Wales, hospital admissions from allcause anaphylaxis increased by 615 % from 1992 to 2012; however, fatalities, checked against a prospective fatal anaphylaxis registry, remained stable at 0.047 cases/ million population.</s><s>Admission rates and fatality rates for anaphylaxis from drugs and insect stings were highest in the elderly.</s><s>Admission rates for food-induced anaphylaxis were highest in young people, with a sharp peak in the incidence of food anaphylaxis fatalities in the second and third decades of life <ref type="bibr" target="#b11">[12]</ref>.</s></p><p><s>From 1999 to 2009, although hospitalizations for anaphylaxis increased in the USA (annual percentage change 2.2 %), this contrasted with a decreased case fatality rate among emergency department (ED) patients and hospitalized patients (annual percentage change −2.35 %).</s><s>Overall mortality rates ranged from 0.63 -0.76/million population (186-225 deaths per year) and appeared stable during the decade studied <ref type="bibr" target="#b12">[13]</ref>.</s><s>In another review of 2458 anaphylaxis fatalities from 1999 to 2010, drugs (58.8 %) were the most common trigger followed by unspecified inducers <ref type="bibr">(19.3 %)</ref>, venoms (15.2 %) and foods (6.7 %).</s><s>Fatalities were associated with older age and other demographic factors <ref type="bibr" target="#b13">[14]</ref>.</s></p><p><s>Anaphylaxis has been misclassified in both the International Classification of Diseases (ICD)-9 and ICD-10 versions.</s><s>The global allergy community views the 11th revision, ICD-11, as an opportunity to improve the classification and coding of hypersensitivity/allergic diseases and is aiming to have a specific chapter on these diseases included to facilitate future epidemiological studies <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient risk factors and amplifying co-factors in anaphylaxis</head><p><s>Many publications now include information on patient risk factors and amplifying co-factors in anaphylaxis  (Table <ref type="table">1</ref>).</s><s>These risk factors and co-factors differ from one age group to another.</s><s>They are not yet optimally studied in the pediatric population.</s></p><p><s>In infancy, there is a paucity of anaphylaxis data because of under-recognition and under-diagnosis due to ageunique symptom patterns.</s><s>In order to increase awareness of anaphylaxis in this age group, illustrated pathways for clinical diagnosis, management and prevention of recurrences in infants have been developed <ref type="bibr" target="#b18">[19]</ref>, based on the WAO Guidelines <ref type="bibr" target="#b0">[1]</ref>.</s></p><p><s>In teenagers, there is an increased risk of severe and/ or fatal anaphylaxis, as reported in several different types of studies.</s><s>For example, in those who developed life-threatening anaphylaxis during food oral immunotherapy (OIT) studies, relevant endogenous risk factors included being an adolescent and having uncontrolled asthma, while relevant exogenous co-factors included lack of compliance with asthma preventer medications and/or with OIT protocols, in addition to exercise, fasting, denial of symptoms, and delay in seeking help <ref type="bibr" target="#b19">[20]</ref>.</s></p><p><s>In pregnancy, anaphylaxis is uncommon, but potentially catastrophic because it can place mothers and infants at high risk for hypoxic-ischemic encephalopathy or death.</s><s>Performing skin tests and challenge tests and initiating allergen immunotherapy are typically avoided because of the associated small, although definite, risk of anaphylaxis.</s><s>A new algorithm for the investigation of anaphylaxis to RhD immunoglobulin G (anti-D) has</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Epidemiology and patient risk factors</head><p><s>Epidemiology <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> Hospitalization rates for anaphylaxis continue to increase year-on-year <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s></p><p><s>Anaphylaxis fatality rates have remained stable or decreased slightly.</s><s>Fatalities are age-, co-morbidity-, and trigger-related <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref>.</s></p><p><s>The highest hospital admission rates for food-induced anaphylaxis occur in very young children age 0-4 years; however, the rate of increase in the age groups 5-14 years and 15-29 years is accelerating <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>Patient risk factors and amplifying co-factors  Data from an anaphylaxis registry of more than 5000 patients with systemic allergic reactions indicated that although monotherapy with beta-blockers and to a lesser extent, ACE inhibitors, increased the risk of severe anaphylaxis, the risk was further increased by concurrent use of a drug from each class <ref type="bibr" target="#b25">[26]</ref>.</s></p><p><s>In an experimental model, although a beta-blocker (metoprolol) given alone had a modestly aggravating effect and an ACE inhibitor (ramipril) given alone had no significant effect, anaphylaxis was exacerbated and mediator release was increased when these medications were given concurrently <ref type="bibr" target="#b25">[26]</ref>.</s></p><p><s>In vitro, FcεRI-mediated mast cell histamine release was not increased by metoprolol or ramipril given alone, but was synergistically increased when the drugs were given together.</s><s>This three-part study provides epidemiologic and experimental evidence that ACE inhibitors and beta-blockers aggravate anaphylaxis partly as a result of direct mast cell priming and decreasing the threshold for mast cell activation <ref type="bibr" target="#b25">[26]</ref>.</s></p><p><s>In a prospective study of co-factors that amplify anaphylaxis, wheat-dependent, exercise-induced anaphylaxis occurred when plasma gliadin levels were elevated by ingestion of higher gluten doses, gluten and exercise, or gluten and acetylsalicylic acid plus alcohol <ref type="bibr" target="#b35">[36]</ref>.</s></p><p><s>ACE angiotensin-converting enzyme inhibitor been proposed to minimize the need for anti-D challenges in pregnant Rh-negative women.</s><s>It includes a detailed history, limited skin testing, and fetal Rh genotyping from maternal blood <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b20">21]</ref>.</s></p><p><s>Old age, combined with co-morbidities such as cardiovascular disease (CVD) and chronic obstructive pulmonary disease, is an important risk factor for severe anaphylaxis with hospitalization, prolonged hospital stay, and fatality <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s>Some widely used life-saving medications for CVD such as beta-blockers and angiotensinconverting enzyme (ACE) inhibitors appear to increase the risk of, or severity of, anaphylaxis; however, their interactions and mechanisms of action are still incompletely understood <ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref>.</s></p><p><s>In a registry involving more than 5000 patients with acute allergic reactions, there was a higher risk of severe anaphylaxis in patients taking a beta-blocker and an ACE inhibitor concurrently than when a beta-blocker or an ACE inhibitor were given alone <ref type="bibr" target="#b25">[26]</ref>.</s><s>These findings were confirmed in an experimental model in which metoprolol given alone had some aggravating effect and ramipril given alone had no significant effect, but anaphylaxis symptoms were exacerbated and mediator release was increased when they were given in combination <ref type="bibr" target="#b25">[26]</ref>.</s><s>In vitro, FcεRI-mediated mast cell histamine release was increased by metoprolol and ramipril given together, whereas these substances had no significant effect when given alone; the mechanism likely involved direct mast cell priming and a decrease in the threshold for mast cell activation <ref type="bibr" target="#b25">[26]</ref>.</s></p><p><s>Systemic mastocytosis may predispose to severe lifethreatening anaphylaxis.</s><s>Although many patients with this disorder have few or no mediator-related symptoms, others have recurrent episodes of severe anaphylaxis with clear signs of a mast cell activation syndrome (MCAS).</s><s>Some patients with systemic mastocytosis have IgE-dependent symptoms; however, the severity and frequency of MCAS reactions do not correlate with specific IgE levels, basal tryptase levels, or the burden of neoplastic mast cells <ref type="bibr" target="#b26">[27]</ref>.</s><s>Other patients have unexplained recurrent episodes of severe anaphylaxis with CVD symptoms such as syncope and elevated basal tryptase levels (&gt;11.4 mcg/L) <ref type="bibr" target="#b27">[28]</ref>.</s></p><p><s>Patients who have indolent systemic mastocytosis (ISM) without skin signs, and anaphylaxis triggered exclusively by insect stings, have clinical and laboratory features that differ significantly from other patients with ISM.</s><s>In this distinct subgroup, males predominate, basal tryptase levels are not greatly elevated, KIT mutations are frequently restricted to bone marrow mast cells, and there are few bone marrow mast cell aggregates <ref type="bibr" target="#b28">[29]</ref>.</s></p><p><s>A rapid inexpensive screening test for the KIT D816V mutation in peripheral blood has been developed.</s><s>This test facilitated recognition of systemic mastocytosis in 4/113 consecutive adult patients with anaphylaxis who had normal or low basal serum tryptase levels and absent or inconspicuous urticaria pigmentosa skin lesions <ref type="bibr" target="#b29">[30]</ref>.</s></p><p><s>More studies on elevation of basal levels of mediators as a risk factor for anaphylaxis are being published.</s><s>Elevated tryptase levels are found to be a good marker for predicting Hymenoptera venom-induced anaphylaxis <ref type="bibr" target="#b30">[31]</ref>.</s><s>In a controlled study, low basal levels of plateletactivating factor (PAF) acetylhydrolase (leading to increased PAF levels) were also associated with severe venom anaphylaxis <ref type="bibr" target="#b31">[32]</ref>.</s><s>A large extended family with Mendelian inheritance of elevated basal tryptase levels included members with MCAS, anaphylaxis, atopy, and connective tissue abnormalities <ref type="bibr" target="#b32">[33]</ref>.</s></p><p><s>Co-factors, including exercise, ethanol, non-steroidal anti-inflammatory drugs (NSAIDs), acute infections, stress, and perimenstrual status potentially amplify anaphylaxis by decreasing the threshold of allergen exposure (the allergen "dose") needed to trigger anaphylaxis and by amplifying the risk of anaphylaxis in patients with low or borderline allergen sensitization <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>.</s></p><p><s>The proposed pathophysiologic mechanisms underlying EIA require prospective testing <ref type="bibr" target="#b34">[35]</ref>.</s><s>As an example, in a controlled study in 16 adults with a history of wheatdependent, exercise-induced anaphylaxis (WDEIA) and omega-5-gliadin-specific IgE, prospective oral food challenges (OFCs) with increasing amounts of gluten alone, or in combination with one or more co-factors, were performed until symptoms developed.</s><s>Plasma gliadin levels were elevated by higher gluten doses, gluten and exercise, or gluten and acetylsalicylic acid (ASA) plus alcohol.</s><s>Positive plasma gliadin threshold levels differed by more than 100-fold (median 628 pg/mL, range .</s><s>In some patients, exercise was not an essential trigger for symptoms <ref type="bibr" target="#b35">[36]</ref>.</s></p><p><s>Perimenstrual anaphylactic episodes in girls and women are attributed to various mechanisms such as hypersensitivity to progesterone or prostaglandin.</s><s>Estrogen might also play a role by enhancing endothelial expression of nitric oxide synthase and nitric oxide production, increasing vascular permeability, and intensifying anaphylaxis severity <ref type="bibr" target="#b36">[37]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Triggers of anaphylaxis</head><p><s>Globally important triggers (inducers) of anaphylaxis such as foods, stinging insect venoms, and drugs remain a major research focus  (Table <ref type="table">2</ref>).</s></p><p><s>In a large European registry study, standardized data are being collected from patients with anaphylaxis referred to allergy/immunology clinics, facilitating accurate comparison of triggers, symptom patterns, and treatment trends across countries <ref type="bibr" target="#b37">[38]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Food-induced anaphylaxis</head><p><s>The immunopathology of food-induced anaphylaxis, tests to confirm specific triggers, and approaches to management have been reviewed in depth <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>.</s><s>Foods are by far the most common anaphylaxis trigger in infants, children, teens, and young adults <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref>.</s><s>As reported in a meta-analysis of data from 34 studies, the incidence rate of food-induced anaphylaxis was 0.14 per 100 person-years at all ages, and up to 7 per 100 personyears in children aged 0-4 years <ref type="bibr" target="#b40">[41]</ref>.</s></p><p><s>In a retrospective study of 168 adults aged &gt;18 years with new-onset food allergy, symptoms typically began in the second and third decades; 49 % of these patients reported anaphylaxis.</s><s>Shellfish, tree nuts, fish, soy, and peanut accounted for most cases, although many other foods were implicated <ref type="bibr" target="#b41">[42]</ref>.</s></p><p><s>A 3 year follow-up study in 80 children with ED visits for systemic allergic reactions (SARs) to foods who had 116 repeat ED visits confirmed that severity of previous reactions did not predict severity of subsequent reactions <ref type="bibr" target="#b42">[43]</ref>.</s></p><p><s>In the past two decades, cashew has become an important allergen due to increased consumption.</s><s>Like other tree nuts and peanuts, it contains potent allergens that can trigger severe anaphylaxis when ingested in trace amounts.</s><s>Cross-reactivity with pistachio is reported <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b43">44]</ref>.</s></p><p><s>In a prospective controlled study, 10 of 12 patients with a history of urticaria after ingestion of mammalian meat developed reactions ranging from urticaria to anaphylaxis within 3-7 hours of an open OFC with meat.</s><s>Basophil activation (increased CD63 expression) correlated with symptom onset, likely reflecting antigen (galactose-alpha 1,3-galactose [alpha-gal]) appearance in the blood.</s><s>None of the 13 control subjects developed symptoms <ref type="bibr" target="#b44">[45]</ref>.</s></p><p><s>In patients with alpha-gal-induced anaphylaxis, pork kidney elicited symptoms and positive skin prick tests (SPT) more consistently than pork muscle meat, attributed to higher alpha-gal concentrations (or more accessible alpha-gal epitopes) in pork kidney compared with muscle.</s><s>Co-factors, including alcohol, NSAIDs, and exercise amplified low levels of sensitization to alpha-gal <ref type="bibr" target="#b33">[34]</ref>.</s></p><p><s>Anaphylaxis has been reported from Japan in patients who ingested okonomiyaki pancakes made from mitecontaminated pancake mix and who had elevated specific IgE to Dermatophagoides and Tyrophagus species <ref type="bibr" target="#b45">[46]</ref>.</s></p><p><s>In pharmaceutical formulations and other manufactured products, foods and food derivatives used as excipients include: egg protein, egg lecithin, fish protamine, fish oil, gelatin (bovine or porcine), casein, lactalbumin, lactose, peanut oil, sesame oil, soy lecithin, soy oil, and soy phosphatidylcholine <ref type="bibr" target="#b46">[47]</ref>.</s><s>Anaphylaxis has been reported in children with milk allergy and asthma treated with lactose-containing intravenous (IV) formulation of methylprednisolone sodium succinate <ref type="bibr" target="#b47">[48]</ref>, and lifethreatening anaphylaxis has been reported after topical exposure to casein in an Everlast kickboxing glove <ref type="bibr" target="#b48">[49]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Insect sting or bite-induced anaphylaxis</head><p><s>Many people in the general population who have tolerated previous insect stings are sensitized to Hymenoptera venom <ref type="bibr" target="#b49">[50,</ref><ref type="bibr" target="#b50">51]</ref>.</s><s>In a prospective study to test the relevance of asymptomatic sensitization, 94 such individuals had venom skin tests (prick and intradermal), specific IgE levels, component-resolved diagnosis, and basophil activation tests (BATs), followed by physiciansupervised challenge stings from one or more live insects.</s><s>Large local reactions occurred in 43.6 % (a 9.5-fold Table <ref type="table">2</ref> Food, insect sting, and drug/iatrogenic triggers Food <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref> In a prospective study, 10/12 patients with IgE-mediated mammalian meat-induced systemic allergic reactions had OFCs with meat.</s><s>Symptom onset occurred in 3-7 hours and correlated with basophil activation and increased CD63 expression, likely reflecting the appearance of galactose-alpha 1,3-galactose (alpha-gal) in the blood.</s><s>Controls remained asymptomatic after OFCs <ref type="bibr" target="#b44">[45]</ref>.</s></p><p><s>Attributed to higher alpha-gal concentrations (or more accessible alpha-gal epitopes), pork kidney elicited symptoms and positive skin tests more consistently than pork muscle meat.</s><s>Co-factors, including alcohol, NSAIDs, and exercise, amplified low levels of alpha-gal sensitization <ref type="bibr" target="#b33">[34]</ref>.</s></p><p><s>Hymenoptera Venom <ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref> The relevance of asymptomatic sensitization to Hymenoptera venom was tested in 94 people who had previously tolerated field stings without a systemic allergic reaction.</s><s>On screening, they had elevated venom-specific IgE levels.</s><s>They underwent a complete evaluation (skin tests, component-resolved diagnosis, BATs, and physician-supervised insect sting challenges).</s><s>Large local reactions occurred in 43.6 %, and systemic reactions occurred in 5.3 %.</s><s>Current venom allergy tests did not distinguish asymptomatic sensitization from risk of local or systemic reactions <ref type="bibr" target="#b51">[52]</ref>.</s></p><p><s>The predictive value of in vitro tests with Hymenoptera venoms can be improved by use of recombinant venom allergens and component resolved testing, for example, by utilizing a panel of honeybee allergens that are free from cross-reactive carbohydrate determinants <ref type="bibr" target="#b52">[53,</ref><ref type="bibr" target="#b53">54]</ref>.</s></p><p><s>Drugs/Iatrogenic Agents  The health consequences of penicillin "allergy" included costly longer admissions, greater use of broad-spectrum antibiotics, and increased prevalence of serious infections with Clostridium difficile, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci <ref type="bibr" target="#b57">[58]</ref>.</s></p><p><s>Risk factors for fatal anaphylaxis to a neuromuscular blocker included male sex, emergency setting, CVD/hypertension, concurrent beta-blocker treatment, and obesity <ref type="bibr" target="#b70">[71]</ref>.</s></p><p><s>Of 228 consecutive patients with perioperative anaphylaxis, 9.6 % were sensitized to the antiseptic/disinfectant chlorhexidine, as determined using specific IgE measurements, basophil activation tests, and standardized skin tests <ref type="bibr" target="#b72">[73]</ref>.</s></p><p><s>alpha-gal galactose-alpha 1,3-galactose; BATs basophil activation tests, CVD cardiovascular disease, NSAIDs non-steroidal anti-inflammatory drugs; OFCs oral food challenges increased risk versus asymptomatic, unsensitized individuals), and SARs occurred in 5.3 %, suggesting that currently available tests cannot distinguish asymptomatic sensitization from the risk of large local reactions or SARs <ref type="bibr" target="#b51">[52]</ref>.</s></p><p><s>Patients who are clinically allergic to Hymenoptera venom yet have absent or undetectable venom-specific IgE can be identified by measuring serum IgE to a panel of recombinant honeybee and yellow jacket venom allergens (rVes v 1, rVes v 2, rVes v 3, and rVes v 5, and rApi m 1, rApi m 2, rApi m 3 and rApi m 5).</s><s>Use of recombinant allergens significantly increases test sensitivity, as compared with specific IgE measurements to commercial venom extracts <ref type="bibr" target="#b52">[53]</ref>.</s></p><p><s>Improved in vitro tests for patients with honeybee venom allergy are being developed.</s><s>Analysis of a panel of cross-reactive carbohydrate determinant-free honeybee venom allergens improved diagnostic sensitivity compared with use of rApi m 1 alone, identified additional major allergens, and revealed sensitization to allergens that have been reported to be absent or under-represented in commercial venom extracts <ref type="bibr" target="#b53">[54]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug-induced anaphylaxis</head><p><s>Drugs, most commonly antibiotics, NSAIDs, and neuromuscular blocking agents (NMBAs), are frequent triggers of anaphylaxis.</s><s>Drug-induced anaphylaxis is underrecognized.</s><s>It can also be over-diagnosed based on history alone.</s><s>Allergy/immunology evaluations are underutilized.</s><s>Immediate reactions occurring within one hour after dosing are typically mediated by specific IgE.</s><s>Skin testing is validated for beta-lactam antibiotics, but less so for other antibiotics and for other drug classes.</s><s>Drug provocation tests are useful in selected patients <ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref>.</s></p><p><s>A history of penicillin "allergy" has important health consequences.</s><s>In a cohort of 51,582 hospitalized US patients versus matched controls, those with a history of penicillin "allergy" had significantly longer admissions, greater use of broad-spectrum antibiotics including fluoroquinolones, clindamycin, and vancomycin, and increased prevalence of serious infections including Clostridium difficile, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococcal infections <ref type="bibr" target="#b57">[58]</ref>.</s><s>In a UK teaching hospital, the total cost of antibiotics prescribed for patients reporting "penicillin allergy" was 1.8 to 2.6-fold higher than for first-line antibiotics <ref type="bibr" target="#b58">[59]</ref>.</s></p><p><s>Assessment by history and skin tests can rule out the likelihood of an acute allergic reaction to penicillins in 90-95 % of patients with a history of penicillin allergy, potentially leading to large cost savings in health systems.</s><s>Skin testing with commercially available benzyl penicilloyl-polylysine (PrePen), previously validated in adults, has now also been validated in children <ref type="bibr" target="#b59">[60]</ref>.</s></p><p><s>Physician-documented cephalosporin anaphylaxis is rare.</s><s>In a large US healthcare system, anaphylaxis occurred during only five oral cephalosporin exposures among 901,908 oral courses and during only eight parenteral cephalosporin exposures among 487,630 parenteral courses <ref type="bibr" target="#b60">[61]</ref>.</s></p><p><s>Although many penicillin-allergic patients can tolerate aztreonam or carbapenems, rare cross-reactivity between penicillins and these drugs has been reported.</s><s>Of 212 consecutive patients with a penicillin allergy history and positive skin tests to one or more penicillins, all had negative skin tests to aztreonam and three carbapenems (imipenem-cilastatin, meropenem, and ertapenem).</s><s>Of the 211 patients who consented to challenge, all passed.</s><s>Pre-treatment skin tests with aztreonam and carbapenems are nevertheless still recommended because negative tests indicate tolerability <ref type="bibr" target="#b61">[62]</ref>.</s></p><p><s>In contrast, skin tests cannot be relied on to confirm hypersensitivity to quinolones.</s><s>Drugs such as moxifloxacin frequently produce positive skin test responses in healthy individuals, and testing with high concentrations does not distinguish between patients with a history of reactions and control patients who have been exposed <ref type="bibr" target="#b62">[63]</ref>.</s></p><p><s>Few cases of anaphylaxis to macrolide antibiotics such as erythromycin or clarithromycin have been reported to date.</s><s>Azithromycin-induced anaphylaxis has been confirmed by skin testing in three children <ref type="bibr" target="#b63">[64]</ref>.</s></p><p><s>NSAIDs are major triggers of anaphylaxis <ref type="bibr" target="#b64">[65,</ref><ref type="bibr" target="#b65">66]</ref>.</s><s>In the Portuguese Pharmacovigilance system, over 4 years, they were responsible for 47.9 % of drug-induced anaphylaxis episodes and 25.6 % of anaphylaxis recurrences.</s><s>Implicated drugs included preferential COX-1 inhibitors such as ASA, diclofenac, ibuprofen, naproxen, and, uncommonly, weak COX-1 inhibitors such as paracetamol (acetaminophen) <ref type="bibr" target="#b65">[66]</ref>.</s></p><p><s>Nine cases of IgE-dependent anaphylaxis to diclofenac were recorded over a decade by the Allergy Vigilance Network in France.</s><s>Sensitization to diclofenac was confirmed in four of these patients by positive intradermal tests, in one patient who developed acute urticaria after intradermal testing, and in one skin test-negative patient who developed anaphylaxis after an oral challenge with diclofenac.</s><s>The investigators emphasized the need for development of tests to measure specific IgE to frequently used NSAIDs such as diclofenac and ibuprofen <ref type="bibr" target="#b66">[67]</ref>.</s></p><p><s>Administration of any drug by any route can potentially cause anaphylaxis.</s><s>As an example, 3.5 % of 230 patients developed anaphylaxis within one hour of subcutaneous injection of the plasma kallikrein inhibitor ecallantide.</s><s>There was no consistent association with IgE to ecallantide or to Pichia pastoris, the yeast cells in which ecallantide is produced by recombinant DNA technology <ref type="bibr" target="#b67">[68]</ref>.</s></p><p><s>Hypersensitivity reactions ranging from mild skin reactions to life-threatening anaphylaxis from biological agents such as rituximab, trastuzumab, cetuximab, ofatumumab, tocilizumab, and brentuximab are increasing in frequency as use of these potentially life-saving agents increases in neoplastic, auto-immune and inflammatory diseases.</s><s>Desensitization enables patients to receive a full treatment regimen of these agents without developing anaphylaxis <ref type="bibr" target="#b68">[69]</ref>.</s></p><p><s>Perioperative anaphylaxis, a serious complication, is reported in up to 1/13,000 anesthetics.</s><s>It can be caused by NMBAs such as atracurium, suxamethonium, rocuronium, or vecuronium; or by antibiotics, blood and blood products, dyes, chlorhexidine, or natural rubber latex.</s><s>In a prospective study, 13 of 4595 (1 in 353) patients having a general anesthetic met referral criteria for investigation of perioperative anaphylaxis, suggesting that the problem is under-diagnosed <ref type="bibr" target="#b69">[70]</ref>.</s><s>From 2000 to 2011, 2022 cases of NMBA anaphylaxis, 84 (4.1 %) of which were fatal, were reported to the French National Pharmacovigilance Network.</s><s>Independent risk factors associated with death were: male gender, emergency setting, history of hypertension or other CVD, ongoing beta-blocker treatment, and obesity <ref type="bibr" target="#b70">[71]</ref>.</s></p><p><s>In 14 of 15 patients with perioperative anaphylaxis due to sugammadex injection for reversal of neuromuscular blockade, symptoms began within four minutes of the sugammadex injection <ref type="bibr" target="#b71">[72]</ref>.</s></p><p><s>Chlorhexidine, an antiseptic/disinfectant active against a broad spectrum of bacteria, viruses, and fungi, is an increasingly common anaphylaxis trigger found in skin cleansers, central venous lines, urinary catheters, and other products.</s><s>Chlorhexidine sensitization was identified in 9.6 % of 228 patients with perioperative anaphylaxis by using specific IgE measurements, BAT, and standardized SPT and intradermal tests <ref type="bibr" target="#b72">[73]</ref>.</s></p><p><s>Natural rubber latex allergy remains an important anaphylaxis trigger in many countries.</s><s>In Israel, prospective use of a 9-item written screening questionnaire before elective Caesarean delivery identified potential clinical reactivity to latex in 14.6 % of 453 women, compared with identification of potential reactivity in only 2.6 % of 460 women who answered a standard verbal inquiry <ref type="bibr" target="#b73">[74]</ref>.</s></p><p><s>Of 104 patients with iodinated radiocontrast media (RCM)-induced anaphylaxis, 34.6 % developed it on their first RCM exposure.</s><s>Patients presenting with shock were older and had more frequent RCM exposures.</s><s>In the 51 patients who were skin tested, the overall positivity rate was 64.7 % and in those with shock, it was 81.8 % <ref type="bibr" target="#b74">[75]</ref>.</s></p><p><s>Although gadolinium-based contrast agents are recommended in patients with a history of RCM-induced anaphylaxis, they, too, can trigger anaphylaxis.</s><s>Of 614 cases reported to the US Food and Drug Administration's Adverse Event Reporting System, 43 % were associated with gadopentetate dimeglumine, 29 % with gadobenate dimeglumine, and 17 % with gadoteridol <ref type="bibr" target="#b75">[76]</ref>.</s></p><p><s>In a case series of anaphylaxis to IV fluorescein, the most common presentation was hypotension, typically occurring within three minutes of dye infusion <ref type="bibr" target="#b76">[77]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Diagnosis of anaphylaxis</head><p><s>Diagnosis of anaphylaxis depends on recognition of characteristic symptoms and signs that occur minutes to hours after exposure to a known or potential trigger <ref type="bibr" target="#b0">[1]</ref>.</s><s>High-quality studies relevant to clinical diagnosis and laboratory tests to support the diagnosis of anaphylaxis are being published <ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref><ref type="bibr" target="#b79">[80]</ref><ref type="bibr" target="#b80">[81]</ref><ref type="bibr" target="#b81">[82]</ref><ref type="bibr" target="#b82">[83]</ref><ref type="bibr" target="#b83">[84]</ref><ref type="bibr" target="#b84">[85]</ref><ref type="bibr" target="#b85">[86]</ref><ref type="bibr" target="#b86">[87]</ref><ref type="bibr" target="#b87">[88]</ref><ref type="bibr" target="#b88">[89]</ref><ref type="bibr" target="#b89">[90]</ref> (Table <ref type="table">3</ref>).</s></p><p><s>The major anaphylaxis guidelines include the National Institute of Allergy and Infectious Diseases clinical criteria for diagnosis, a practical instrument for rapid identification of patients with a likely diagnosis of Table <ref type="table">3</ref> Diagnosis, initial treatment, and self-treatment in community settings</s></p><p><s>Diagnosis <ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref><ref type="bibr" target="#b79">[80]</ref><ref type="bibr" target="#b80">[81]</ref><ref type="bibr" target="#b81">[82]</ref><ref type="bibr" target="#b82">[83]</ref><ref type="bibr" target="#b83">[84]</ref><ref type="bibr" target="#b84">[85]</ref><ref type="bibr" target="#b85">[86]</ref><ref type="bibr" target="#b86">[87]</ref><ref type="bibr" target="#b87">[88]</ref><ref type="bibr" target="#b88">[89]</ref><ref type="bibr" target="#b89">[90]</ref> In a prospective controlled study of ED patients with anaphylaxis, up-regulation of innate inflammatory gene networks was reported.</s><s>On ED arrival, two genes were expressed; one hour after arrival, 67 genes were expressed; and three hours after arrival, 2801 genes were expressed.</s><s>Genomic responses provide new insights into the potential release of a cascade of mediators in anaphylaxis <ref type="bibr" target="#b89">[90]</ref>.</s></p><p><s>Initial treatment <ref type="bibr" target="#b90">[91]</ref><ref type="bibr" target="#b91">[92]</ref><ref type="bibr" target="#b92">[93]</ref><ref type="bibr" target="#b93">[94]</ref><ref type="bibr" target="#b94">[95]</ref><ref type="bibr" target="#b95">[96]</ref><ref type="bibr" target="#b96">[97]</ref><ref type="bibr" target="#b97">[98]</ref><ref type="bibr" target="#b98">[99]</ref><ref type="bibr" target="#b99">[100]</ref><ref type="bibr" target="#b100">[101]</ref><ref type="bibr" target="#b101">[102]</ref><ref type="bibr" target="#b102">[103]</ref> Early injection of epinephrine in anaphylaxis, defined as initial injection before ED arrival, significantly reduced the likelihood of hospital admission, compared with initial epinephrine injection after ED arrival <ref type="bibr" target="#b91">[92]</ref>.</s></p><p><s>Epinephrine was injected before cardiac arrest in only 23 % of 92 individuals who experienced a fatal anaphylaxis episode <ref type="bibr" target="#b92">[93]</ref>.</s></p><p><s>In an observational study, data confirmed the safety of IM epinephrine injection, typically given through an epinephrine auto-injector: (adverse events 1 %, and no overdoses).</s><s>In contrast, IV bolus injections were associated with significantly more adverse events (10 %) and overdoses (13 %) <ref type="bibr" target="#b98">[99]</ref>.</s></p><p><s>In a systematic review and meta-analysis of 27 studies, 4.7% of 4114 patients with anaphylaxis had biphasic episodes (range 0.4% to 23.3%).</s><s>Patients who presented with hypotension or who had an unknown inciting trigger were at increased risk.</s><s>The data suggested that for patients with anaphylaxis who are treated successfully in an ED, the duration of observation should be risk-stratified according to the clinical characteristics and severity of the episode <ref type="bibr" target="#b100">[101]</ref>.</s></p><p><s>Long-term management: self-treatment in community settings <ref type="bibr" target="#b103">[104]</ref><ref type="bibr" target="#b104">[105]</ref><ref type="bibr" target="#b105">[106]</ref><ref type="bibr" target="#b106">[107]</ref><ref type="bibr" target="#b107">[108]</ref><ref type="bibr" target="#b108">[109]</ref><ref type="bibr" target="#b109">[110]</ref><ref type="bibr" target="#b110">[111]</ref><ref type="bibr" target="#b111">[112]</ref><ref type="bibr" target="#b112">[113]</ref><ref type="bibr" target="#b113">[114]</ref><ref type="bibr" target="#b114">[115]</ref><ref type="bibr" target="#b115">[116]</ref><ref type="bibr" target="#b116">[117]</ref><ref type="bibr" target="#b117">[118]</ref> Patients who were treated in an ED for anaphylaxis benefited from referral to A/I specialists who clarified the diagnosis and correctly identified and confirmed specific anaphylaxis triggers <ref type="bibr" target="#b103">[104]</ref>.</s></p><p><s>Novel EAIs are now available in some countries.</s><s>The compact Auvi-Q can be used correctly on first attempt by 93 % of parents who have never seen or heard it before.</s><s>The Emerade is available in 0.15 mg, 0.3 mg, and 0.5 mg doses.</s><s>The 0.3 mg and the 0.5 mg dose EAIs have a 25 mm long needle.</s><s>EAIs differ significantly with regard to size, ease of carrying, ease of use, needle protection, and robustness.</s><s>They are not interchangeable <ref type="bibr" target="#b106">[107,</ref><ref type="bibr" target="#b107">108]</ref>.</s></p><p><s>A/I allergy/immunology, ED emergency department, EAI epinephrine autoinjector, IM intramuscular, IV intravenous anaphylaxis <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b77">78]</ref>.</s><s>These criteria are validated for use in EDs and other medical settings and in epidemiological research, in which they are used to define study populations.</s><s>In order to operationalize them, illustrations <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b18">19</ref>] and a color-coded chart <ref type="bibr" target="#b77">[78]</ref> have been developed.</s></p><p><s>Under-diagnosis of anaphylaxis is common.</s><s>Although over 80 % of 7822 responders (most of whom were physicians or allied healthcare professionals) correctly identified anaphylaxis when given a case scenario of a patient with cutaneous involvement, only 55 % recognized anaphylaxis in a case without cutaneous involvement <ref type="bibr" target="#b78">[79]</ref>.</s><s>Importantly, diagnostic confusion has been reported in children hospitalized for life-threatening asthma, some of whom met diagnostic criteria for anaphylaxis <ref type="bibr" target="#b79">[80]</ref>.</s></p><p><s>Less common considerations in the differential diagnosis also need to be kept in mind, as in the following examples: Anaphylaxis due to ruptured hydatid cyst can occur in areas without endemic Echinococcus granulosus, a reminder that untreated patients who have lived in endemic areas remain at life-long risk <ref type="bibr" target="#b80">[81]</ref>.</s><s>Idiopathic systemic capillary leak syndrome has now been documented in children aged 5-11 years; therefore, in the pediatric population, as in adults, it should be considered in the differential diagnosis of anaphylaxis in patients who present with hypotension, shock, and fluid extravasation <ref type="bibr" target="#b81">[82]</ref>.</s></p><p><s>In addition, misdiagnosis or over-diagnosis of anaphylaxis can occur, as described in patients with acute multisystem symptoms after ingestion of caustic substances, and those with foreign body inhalation, acute urticaria, or angioedema <ref type="bibr" target="#b82">[83,</ref><ref type="bibr" target="#b83">84]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Role of laboratory tests</head><p><s>Serum tryptase levels in blood samples taken 15-180 minutes after symptom onset can support the clinical diagnosis of anaphylaxis in some but not all patients <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>In food-induced anaphylaxis, single tryptase measurements are typically within the normal reference range; however, in these patients, use of a ratio (peak tryptase level divided by basal level) is reported to improve sensitivity, specificity, and positive and negative likelihood ratios <ref type="bibr" target="#b84">[85]</ref>.</s></p><p><s>In perioperative anaphylaxis, serum tryptase levels are not compromised by large volumes of fluid or by resuscitation <ref type="bibr" target="#b85">[86]</ref>.</s><s>An elevated "acute" serum tryptase level (% change &gt;141 %; or absolute tryptase level of &gt;15.7 mcg/L) has been reported to be highly predictive of IgE-mediated perioperative anaphylaxis in a multi-center, retrospective analysis <ref type="bibr" target="#b86">[87]</ref>.</s></p><p><s>In post-mortem sera, serum tryptase levels can vary in the same person depending on the site of blood sampling; moreover, elevated levels are not specific for anaphylaxis, but can also occur in people who die from myocardial infarction, asphyxia, or trauma <ref type="bibr" target="#b87">[88]</ref>.</s></p><p><s>Even when tryptase levels are within the normal reference range, other mediators of inflammation such as histamine, PAF, PGD2, and LTE4 can be elevated in anaphylaxis <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s><s>Heparin, the contact system, and activation of factor-XII are also involved in anaphylaxis, generating plasma kallikrein that protealyzes kininogen and leads to bradykinin release; moreover, the intensity of contact system activation and bradykinin formation are associated with anaphylaxis severity <ref type="bibr" target="#b88">[89]</ref>.</s></p><p><s>Reliance on elevation of only one mediator of inflammation to confirm the clinical diagnosis of anaphylaxis is likely insufficient.</s><s>In a prospective controlled study of ED patients with moderately severe anaphylaxis, gene expression in peripheral blood samples was profiled in microarrays, differentially expressed genes were identified, and network analysis was used to explore underlying mechanisms <ref type="bibr" target="#b89">[90]</ref>.</s></p><p><s>In these patients, on ED arrival, two genes were differentially expressed.</s><s>One hour post-arrival, 67 genes were expressed; and three hours post-arrival, 2801 genes were expressed.</s><s>Network analysis demonstrated up-regulation of three inflammatory modules, each containing multiple hub-genes with a central role in the regulation of innate inflammatory responses <ref type="bibr" target="#b89">[90]</ref>.</s></p><p><s>Genomic responses in anaphylaxis provide insight into potential release of a cascade of mediators that might play a role in escalation of anaphylaxis symptoms and signs <ref type="bibr" target="#b89">[90]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Initial treatment of anaphylaxis</head><p><s>Anaphylaxis is a life-threatening medical emergency in which prompt intervention is critical.</s><s>Principles of treatment remain unchanged <ref type="bibr" target="#b0">[1]</ref>; however, recommendations for treatment are based on evidence of increasingly high quality <ref type="bibr" target="#b90">[91]</ref><ref type="bibr" target="#b91">[92]</ref><ref type="bibr" target="#b92">[93]</ref><ref type="bibr" target="#b93">[94]</ref><ref type="bibr" target="#b94">[95]</ref><ref type="bibr" target="#b95">[96]</ref><ref type="bibr" target="#b96">[97]</ref><ref type="bibr" target="#b97">[98]</ref><ref type="bibr" target="#b98">[99]</ref><ref type="bibr" target="#b99">[100]</ref><ref type="bibr" target="#b100">[101]</ref><ref type="bibr" target="#b101">[102]</ref><ref type="bibr" target="#b102">[103]</ref> (Table <ref type="table">3</ref>).</s></p><p><s>International guidelines concur that epinephrine (adrenaline) is the medication of first choice in anaphylaxis because it is the only medication that reduces hospitalization and death.</s><s>Its life-saving alpha-1 agonist vasoconstrictor effects prevent and relieve airway edema, hypotension, and shock; its beta-1 agonist chronotropic and inotropic effects increase the rate and force of cardiac contractions, and its beta-2 agonist effects lead to bronchodilation and decreased mediator release <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b77">78,</ref><ref type="bibr" target="#b90">[91]</ref><ref type="bibr" target="#b91">[92]</ref><ref type="bibr" target="#b92">[93]</ref>.</s></p><p><s>Early injection of epinephrine in anaphylaxis, defined as injection before ED arrival, can significantly reduce the likelihood of hospital admission, as compared with initial injection after ED arrival <ref type="bibr" target="#b91">[92]</ref>.</s><s>Delayed injection of epinephrine has been reported in yet another large series of anaphylaxis-related fatalities in which only 23 % of the 92 individuals received it before cardiac arrest <ref type="bibr" target="#b92">[93]</ref>.</s><s>Although epinephrine injection rates remain low in many EDs <ref type="bibr" target="#b93">[94]</ref>, use of protocols or order sets can significantly improve injection rates <ref type="bibr" target="#b94">[95]</ref>.</s></p><p><s>Epinephrine is significantly less likely to be injected in food-induced anaphylaxis than in venom-induced anaphylaxis <ref type="bibr" target="#b37">[38]</ref>.</s><s>Other reasons for failure to inject it include: not giving it because symptoms appear mild or moderate, or there are perceived contraindications to it (pregnancy, older age, or CVD) <ref type="bibr" target="#b94">[95]</ref><ref type="bibr" target="#b95">[96]</ref><ref type="bibr" target="#b96">[97]</ref>, or the patient refuses it <ref type="bibr" target="#b97">[98]</ref>.</s><s>In fact, there are no absolute contraindications to epinephrine <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>More emphasis is needed on prompt recognition and appropriate treatment of anaphylaxis by healthcare professionals.</s><s>In a 2013 study, although junior doctors' ability to manage anaphylaxis was somewhat improved compared with a similar study in a 2002 physician cohort, only one-third of them knew the correct dose and route for epinephrine administration <ref type="bibr" target="#b83">[84]</ref>.</s></p><p><s>In an ED single-center retrospective observational cohort study of epinephrine safety, 58 % of 573 consecutive patients received epinephrine for anaphylaxis.</s><s>Only four of 316 patients (1 %) who received an intramuscular (IM) epinephrine injection (most doses administered through an auto-injector) developed adverse events; in contrast, three of 30 patients (10 %) who received IV bolus epinephrine had adverse events.</s><s>There were no overdoses with IM injection, versus an overdose rate of 13 % after IV bolus administration.</s><s>These data support the safety of the IM route and suggest need for extreme caution when IV bolus doses are administered <ref type="bibr" target="#b98">[99]</ref>.</s></p><p><s>International guidelines concur that H 1 -antihistamines, H 2 -antihistamines, and glucocorticoids are second-line <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b77">78]</ref> or even third-line <ref type="bibr" target="#b4">[5]</ref> medications in anaphylaxis.</s><s>These medications are not life-saving and should not be used as initial or sole treatment.</s><s>A systematic review of H 2 -antihistamines in anaphylaxis found no randomized controlled trials (RCTs) that met the criteria for inclusion; the H 2 -antihistamines had been studied in acute allergic reactions in which skin symptoms predominated; most (80 %) of the patients had no respiratory or cardiovascular involvement and did not have anaphylaxis <ref type="bibr" target="#b99">[100]</ref>.</s><s>Glucocorticoids are typically administered to prevent biphasic or protracted episodes of anaphylaxis and have little or no effect on initial symptoms and signs <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b77">78]</ref>.</s></p><p><s>In a systematic review and meta-analysis of 27 observational studies, biphasic episodes occurred in 192 (4.7 %) of 4114 patients with anaphylaxis (range 0.4 % to 23.3 %) <ref type="bibr" target="#b100">[101]</ref>.</s><s>Patients with unknown triggers and those presenting with hypotension were at increased risk; those with food-induced anaphylaxis were at decreased risk.</s><s>These data suggest that routine prolonged monitoring is unnecessary in patients whose anaphylaxis symptoms have resolved and that the duration of observation should be risk-stratified according to the clinical characteristics and severity of the episode <ref type="bibr" target="#b100">[101]</ref>.</s></p><p><s>Methylene blue, a selective nitric oxide cyclic GMP inhibitor, prevents vasodilation and can rapidly reverse the course of anaphylaxis refractory to epinephrine, oxygen, and IV fluid resuscitation.</s><s>Use in anaphylaxis is based on case reports and extrapolated from use in septic shock.</s><s>Limitations include adverse events and interference with pulse oximetry <ref type="bibr" target="#b101">[102]</ref>.</s></p><p><s>In patients with life-threatening anaphylaxis, cardiovascular collapse, and cardiac arrest, extracorporeal membrane oxygenation (ECMO) is reported to act as a bridge to recovery <ref type="bibr" target="#b102">[103]</ref>.</s></p><p><s>Long-term management of anaphylaxis in community settings: self-treatment Treatment of anaphylaxis does not end with resolution of an acute episode <ref type="bibr" target="#b0">[1]</ref>.</s><s>Aimed at decreasing anaphylaxis morbidity and mortality in community settings, high-quality studies, including prospective studies of epinephrine auto-injectors (EAIs) and of anaphylaxis education, are being published <ref type="bibr" target="#b103">[104]</ref><ref type="bibr" target="#b104">[105]</ref><ref type="bibr" target="#b105">[106]</ref><ref type="bibr" target="#b106">[107]</ref><ref type="bibr" target="#b107">[108]</ref><ref type="bibr" target="#b108">[109]</ref><ref type="bibr" target="#b109">[110]</ref><ref type="bibr" target="#b110">[111]</ref><ref type="bibr" target="#b111">[112]</ref><ref type="bibr" target="#b112">[113]</ref><ref type="bibr" target="#b113">[114]</ref><ref type="bibr" target="#b114">[115]</ref><ref type="bibr" target="#b115">[116]</ref><ref type="bibr" target="#b116">[117]</ref><ref type="bibr" target="#b117">[118]</ref> (Table <ref type="table">3</ref>).</s><s>Further studies of the long-term benefits of anaphylaxis education are needed.</s></p><p><s>Allergy/immunology specialists clarified the diagnosis or accurately identified and confirmed the specific anaphylaxis trigger in 35 % of patients referred from an ED after treatment for anaphylaxis <ref type="bibr" target="#b103">[104]</ref>.</s><s>Visits to an allergist/immunologist reduced the risk of severe anaphylaxis requiring hospital admission <ref type="bibr" target="#b16">[17]</ref>.</s></p><p><s>In many countries, EAIs are still unavailable <ref type="bibr" target="#b93">[94]</ref>.</s><s>Where they are available, they remain under-prescribed and under-used; as an example, only 11 % of 261 individuals with a history of confirmed anaphylaxis had used an EAI during their most recent episode, and 52 % reported that they had never received an EAI prescription <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b104">105]</ref>.</s><s>In another study, only 16 % of 102 patients could demonstrate the correct use of an EpiPen; most patients made at least one mistake and 56 % of them missed three or more steps <ref type="bibr" target="#b105">[106]</ref>.</s></p><p><s>New EAIs are being developed and introduced.</s><s>In the US and Canada, the Auvi-Q is a user-friendly, uniquelyshaped EAI (not a pen), with audio and visual prompts, and needle protection before and after use <ref type="bibr" target="#b106">[107]</ref>.</s><s>Most parents (93 %) who had never previously seen an Auvi-Q or a demonstration of its use intuitively used it correctly on their first attempt <ref type="bibr" target="#b107">[108]</ref>.</s><s>In Europe, the Emerade is available in a 0.15, 0.3, and 0.5 mg dose, with a 16 mm needle on the 0.15 mg EAI and a 25 mm (1-inch needle) needle on the 0.3 mg EAI and the 0.5 mg EAI.</s></p><p><s>EAIs differ significantly with regard to size, ease of carrying, ease of use, needle protection, and robustness.</s><s>They are not inter-changeable <ref type="bibr" target="#b106">[107,</ref><ref type="bibr" target="#b107">108]</ref>.</s></p><p><s>However, manufacturers' recommendations are similar for all EAIs with regard to storage: keep at 20°to 25 °C (excursions permitted from 15°to 30 °C) to protect the epinephrine solution from degradation and ensure mechanical integrity of the device.</s><s>In a warm climate, the degradation of epinephrine solution in EAIs is potentially accelerated <ref type="bibr" target="#b108">[109]</ref>.</s><s>If EAIs are subjected to freezing temperatures for a few days, no degradation of epinephrine solution occurs; however, they must be completely thawed before use <ref type="bibr" target="#b109">[110]</ref>.</s></p><p><s>Long-term follow-up is important to ensure retention of skills by patients, caregivers, and healthcare professionals.</s><s>As an example,160 medical interns had theoretical training about anaphylaxis and practical demonstrations with EpiPen trainers.</s><s>They were then randomly assigned into one group tested 3 months later and another group tested 6 months later.</s><s>Test scores and EAI demonstration skills, including mean time to "inject epinephrine" from EpiPen trainers, were retained at 3 months, but decreased significantly at 6 months <ref type="bibr" target="#b110">[111]</ref>.</s></p><p><s>Structured education programs improve anaphylaxis management.</s><s>In a prospective study, 98 patients with a history of anaphylaxis and 95 caregivers received two anaphylaxis education modules, each lasting three hours.</s><s>At follow-up 3 months later, those receiving this intervention improved significantly in knowledge and competence in emergency management, and caregiver anxiety was reduced, as compared with controls who received only standard auto-injector training <ref type="bibr" target="#b111">[112]</ref>.</s></p><p><s>An anaphylaxis e-learning program for pharmacists developed by the Australian Society of Clinical Immunology and Allergy was compared with lectures or no training at all.</s><s>Effectiveness was measured using a validated test administered pre-training, immediately post-training, and 3 months and 7 months later.</s><s>The proportion of elearners achieving the minimum standard for anaphylaxis knowledge improved from 45 % at pre-test to 87 % at 7 months, confirming long-term improvement versus comparators <ref type="bibr" target="#b112">[113]</ref>.</s></p><p><s>In many US schools, unassigned EAIs are now available for use in or by students who experience anaphylaxis and do not have a personal EAI available.</s><s>Efforts to reduce disparities in EAI availability within and between school districts are ongoing <ref type="bibr" target="#b113">[114]</ref>.</s></p><p><s>Incorporation of prospectively validated pictograms into a pediatric anaphylaxis emergency action plan potentially increases comprehension of triggers, symptoms and signs, and management <ref type="bibr" target="#b114">[115]</ref>.</s></p><p><s>A nurse delivered a training program in person to 4818 individuals at 247 schools and community sites.</s><s>Written evaluations, online surveys, and phone interviews were used to measure effectiveness.</s><s>In-person training increased participants' knowledge and confidence in prevention, recognition, and treatment of anaphylaxis <ref type="bibr" target="#b115">[116]</ref>.</s></p><p><s>In some countries, school staff are reported to have a low level of preparedness to prevent and manage foodinduced allergic reactions <ref type="bibr" target="#b116">[117]</ref>.</s><s>Guidelines outlining a standardized approach to risk management of patients with food-induced allergic reactions in schools and other community settings have been developed; however, RCTs of the effectiveness of the interventions are needed to strengthen the evidence base for the recommendations <ref type="bibr" target="#b117">[118]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Long-term management: prevention of recurrence</head><p><s>Regular follow-up of all patients at risk of anaphylaxis is an important principle of long-term risk reduction <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>High-quality studies, including RCTs that focus on prevention of anaphylaxis are being published  (Table <ref type="table">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Food-induced anaphylaxis</head><p><s>A detailed history of the anaphylactic episode is a critically important aspect of patient evaluation.</s><s>In interpreting the history, awareness of emerging new allergens and cross-reactivity of homologous allergenic proteins is helpful <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b118">119]</ref>.</s></p><p><s>Based on a retrospective study, for predicting outcomes of OFCs, the ratio of food-specific IgE to total Table <ref type="table">4</ref> Long-term management: trigger-specific prevention Food-induced anaphylaxis <ref type="bibr" target="#b118">[119]</ref><ref type="bibr" target="#b119">[120]</ref><ref type="bibr" target="#b120">[121]</ref><ref type="bibr" target="#b121">[122]</ref><ref type="bibr" target="#b122">[123]</ref><ref type="bibr" target="#b123">[124]</ref><ref type="bibr" target="#b124">[125]</ref><ref type="bibr" target="#b125">[126]</ref><ref type="bibr" target="#b126">[127]</ref><ref type="bibr" target="#b127">[128]</ref><ref type="bibr" target="#b128">[129]</ref><ref type="bibr" target="#b129">[130]</ref><ref type="bibr" target="#b130">[131]</ref><ref type="bibr" target="#b131">[132]</ref><ref type="bibr" target="#b132">[133]</ref><ref type="bibr" target="#b133">[134]</ref> Sustained clinical and immunological unresponsiveness to peanut was documented after up to 5 years of peanut oral immunotherapy.</s><s>Responders had smaller skin test wheals and lower allergen-specific IgE levels at baseline and at the time of post-treatment peanut challenge, compared with non-responders <ref type="bibr" target="#b129">[130]</ref>.</s></p><p><s>Sustained clinical and immunological responsiveness to peanut has been documented after up to 3 years of peanut sublingual immunotherapy.</s><s>Responders had a significant decrease in peanut-specific basophil activation and skin prick test titration with peanut, as compared with non-responders <ref type="bibr" target="#b130">[131]</ref>.</s></p><p><s>In selected high-risk infants with eczema, egg allergy, or both, who were aged 4-10 months (inclusive) at study entry, early introduction of peanut snacks (at least 6 grams weekly until age 60 months) prevented development of clinical reactivity to peanut <ref type="bibr" target="#b133">[134]</ref>.</s></p><p><s>Hymenoptera venom-induced anaphylaxis <ref type="bibr" target="#b134">[135]</ref><ref type="bibr" target="#b135">[136]</ref><ref type="bibr" target="#b136">[137]</ref><ref type="bibr" target="#b137">[138]</ref><ref type="bibr" target="#b138">[139]</ref> In 100 adults who completed venom immunotherapy and had live sting challenges to prove efficacy, post-challenge scores on the Vespid Allergy Quality of Life Questionnaire improved significantly, independent of age, sex, or severity of the initial anaphylaxis episode <ref type="bibr" target="#b137">[138]</ref>.</s></p><p><s>Drug/iatrogenic agent-induced anaphylaxis <ref type="bibr" target="#b139">[140]</ref><ref type="bibr" target="#b140">[141]</ref><ref type="bibr" target="#b141">[142]</ref><ref type="bibr" target="#b142">[143]</ref><ref type="bibr" target="#b143">[144]</ref><ref type="bibr" target="#b144">[145]</ref><ref type="bibr" target="#b145">[146]</ref><ref type="bibr" target="#b146">[147]</ref><ref type="bibr" target="#b147">[148]</ref> In a retrospective study of patients with a history of hypersensitivity reactions during anesthesia, comprehensive evaluation, including skin tests and measurement of basal tryptase levels, followed by development of a management plan, minimized risk of subsequent reactions even when a specific trigger such as an antibiotic, neuromuscular blocker, or latex was not identified <ref type="bibr" target="#b144">[145]</ref>.</s></p><p><s>Idiopathic anaphylaxis <ref type="bibr" target="#b148">[149,</ref><ref type="bibr" target="#b149">150]</ref> In 20 % of 110 patients with idiopathic anaphylaxis (no identifiable trigger by history, skin tests, or allergen-specific IgE levels), the etiology of the episode was identified by using the ImmunoCAP ISAC 103 allergen array in addition to the ImmunoCAP 250 platform.</s><s>Omega-5 gliadin and shrimp were the most frequently identified sensitizations among those not previously recognized <ref type="bibr" target="#b148">[149]</ref>.</s></p><p><s>IgE was more accurate than specific IgE levels alone in confirming development of tolerance <ref type="bibr" target="#b119">[120]</ref>.</s></p><p><s>Component-resolved testing involves identifying specific IgE by using allergenic proteins derived from recombinant DNA technology or purified from natural sources.</s><s>Among 165 consecutive peanut-sensitized children, those clinically reactive to peanut consistently had significantly higher peanut-specific and Ara h 2-specific IgE antibody levels than those who could tolerate peanut ingestion <ref type="bibr" target="#b120">[121]</ref>.</s></p><p><s>Use of the BAT in peanut-sensitized children revealed peanut concentration-dependent up-regulation of CD63 and CD203c in those who were clinically reactive to peanut, contrasting with no significant responses in those who could tolerate peanut ingestion.</s><s>The BAT reduced the number of OFCs required <ref type="bibr" target="#b121">[122]</ref>.</s></p><p><s>The 65-70 % of children destined to outgrow their anaphylactic sensitivity to milk or egg cannot be accurately identified by skin prick tests, nor can specific IgE levels be interpreted as an absolute indication or contraindication to an OFC.</s><s>However, many caregivers can reliably report that their cow's milk-or egg-allergic child already eats and tolerates baked goods such as muffins containing small quantities of extensively-heated milk or egg without developing symptoms.</s><s>For other children, such as a child who has been strictly avoiding cow's milk and related products, a physician-supervised cow's milk OFC is strongly recommended <ref type="bibr" target="#b118">[119,</ref><ref type="bibr" target="#b122">[123]</ref><ref type="bibr" target="#b123">[124]</ref><ref type="bibr" target="#b124">[125]</ref>.</s></p><p><s>Predictors of failure (clinical reactions, including anaphylaxis) during physician-supervised OFCs with baked cow's milk were: asthma, asthma requiring preventer therapy, IgE-mediated clinical reactions to more than three food groups, and a history of anaphylaxis to cow's milk <ref type="bibr" target="#b124">[125]</ref>.</s></p><p><s>A practical guide to managing cow's milk allergy and/ or egg allergy includes recipes for muffins containing baked milk or baked egg suitable for use in physiciansupervised OFCs in hospital settings and instructions for continuing safe introduction of baked milk or baked egg at home after a patient passes an OFC <ref type="bibr" target="#b123">[124]</ref>.</s><s>Useful web-based resources are also available <ref type="bibr" target="#b118">[119]</ref>.</s></p><p><s>Adherence, defined as regular dietary consumption of extensively heated cow's milk or egg, has been documented in two-thirds of children who passed a physician-supervised OFC.</s><s>Children with asthma appear to be at increased risk of ongoing reactivity after passing an OFC <ref type="bibr" target="#b125">[126]</ref>.</s></p><p><s>Based on a validated disease-specific questionnaire, OFCs, regardless of pass or fail outcome, were associated with improved quality-of-life in caregivers of food-allergic children, as compared with caregivers of food-allergic children who did not have OFCs <ref type="bibr" target="#b126">[127]</ref>.</s></p><p><s>Liberalizing the diet is important for children who can tolerate baked milk or baked egg because strict elimination diets, particularly those excluding milk, have been associated with linear growth impairment and nutritional deficiencies, exclusion from social activities, and higher direct costs such as medications and indirect costs such as lost wages and household expenses <ref type="bibr" target="#b127">[128,</ref><ref type="bibr" target="#b128">129]</ref>.</s></p><p><s>RCTs confirm that desensitization can be achieved in many patients who are symptomatic after ingestion of highly allergenic foods such as peanut, milk, or egg <ref type="bibr" target="#b129">[130,</ref><ref type="bibr" target="#b130">131]</ref>.</s><s>During OIT, patients with asthma are at risk for more severe adverse events, including anaphylaxis <ref type="bibr" target="#b19">[20]</ref>, and are less likely to achieve full desensitization than nonasthmatics <ref type="bibr" target="#b131">[132]</ref>.</s><s>The safety of OIT can be improved by omalizumab pre-treatment and co-treatment <ref type="bibr" target="#b39">[40]</ref>.</s></p><p><s>Sustained clinical unresponsiveness to peanut after OIT has been demonstrated in a clinical trial in which children aged 1-16 years were treated with dose increases up to 4000 mg/day peanut protein.</s><s>Double-blind placebo-controlled OFCs with 5000 mg peanut protein (on average, 12 peanuts) were conducted.</s><s>Of 39 participants, 24 completed the protocol and 12 passed the OFC 1 month after stopping treatment.</s><s>This study confirmed sustained unresponsiveness after up to 5 years of peanut OIT.</s><s>Successful outcomes could be predicted by smaller skin test wheals to peanut and lower peanutspecific IgE levels at baseline and at the time of peanut challenge <ref type="bibr" target="#b129">[130]</ref>.</s><s>In an experimental OIT model, IgG antibodies that act through FcγRIIb to suppress IgEmediated hypersensitivity have been induced <ref type="bibr" target="#b132">[133]</ref>.</s></p><p><s>In a 3 year follow-up study of peanut sublingual immunotherapy, in OFCs performed 2 weeks after treatment ended, 11 % of the 40 patients were able to consume 10 grams of peanut powder, equivalent to 16-18 peanuts.</s><s>Approximately 98 % of the 18,165 doses were tolerated without severe symptoms beyond the oropharynx.</s><s>At year 2 of maintenance treatment, responders had a significant decrease in peanut-specific basophil activation and SPT titration compared with non-responders.</s><s>By study's end, 10.8 % of 37 patients achieved sustained unresponsiveness to peanut.</s><s>The drop-out rate was high, mainly due to difficulties in taking the sublingual peanut extract every day <ref type="bibr" target="#b130">[131]</ref>.</s></p><p><s>Prevention of clinical reactivity to peanut may eventually be possible.</s><s>In a landmark RCT, 640 infants with severe eczema, egg allergy, or both, who were age 4-10 months at study entry were assigned to either consume peanuts or avoid peanuts until age 60 months.</s><s>Randomization was based on pre-existing sensitization to peanut as determined by SPT.</s><s>The primary outcome was the proportion of children with peanut allergy at age 60 months.</s><s>In the infants who avoided peanut, the prevalence of peanut allergy was 13.7 %.</s><s>In those who consumed at least 6 grams of a peanut butter-containing snack per week, it was significantly lower (1.9 %).</s><s>In these carefully selected high-risk infants, early introduction of peanut prevented subsequent development of clinical reactivity to peanut <ref type="bibr" target="#b133">[134]</ref>.</s><s>Additional studies of prevention strategies are ongoing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stinging insect-induced anaphylaxis</head><p><s>Venom immunotherapy (VIT) effectively reduces susceptible patients' risk of recurrent SARs.</s><s>The risk continues to decrease the longer VIT is continued.</s><s>The currently recommended duration of VIT is 5 years; however, it should be given for more than 5 years to patients who are at particularly high risk for venom anaphylaxis, including the elderly, those with concomitant cardiac and/or pulmonary disease, elevated basal serum tryptase levels, and SARs before or during VIT.</s><s>Lifelong VIT is the standard of care for patients with clonal mast cell disorders <ref type="bibr" target="#b134">[135]</ref>.</s><s>Omalizumab can be used to facilitate VIT in patients who previously could not tolerate it <ref type="bibr" target="#b135">[136]</ref>.</s></p><p><s>Because of the residual risk of SARs after VIT, all patients should carry EAIs indefinitely and continue to avoid Hymenoptera stings <ref type="bibr" target="#b134">[135]</ref>.</s><s>When teaching patients to avoid stinging insects and their nests, visual aids should be used to aid in recognition <ref type="bibr" target="#b136">[137]</ref>.</s></p><p><s>Sting challenge with a live insect is the only test that accurately evaluates VIT efficacy.</s><s>In 100 adults who had completed VIT, after their sting challenges, scores on the Vespid Allergy Quality-of-Life Questionnaire improved significantly, independent of sex, age, and severity of the initial anaphylactic episode <ref type="bibr" target="#b137">[138]</ref>.</s></p><p><s>In some areas of Australia, jack jumper ant stings are an important cause of anaphylaxis and death.</s><s>Jack jumper ant VIT effectively prevents anaphylaxis recurrences.</s><s>Its tolerability and safety are comparable with those of honeybee VIT <ref type="bibr" target="#b138">[139]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug-induced/iatrogenic anaphylaxis</head><p><s>In patients with a history of anaphylaxis to penicillins, if at all possible, skin tests, even SPT, and challenge tests should be avoided, because they can trigger anaphylaxis <ref type="bibr" target="#b139">[140,</ref><ref type="bibr" target="#b140">141]</ref>.</s></p><p><s>In contrast, many (90 %) low-risk penicillin allergylabeled patients who have no history of anaphylaxis or other penicillin-associated serious life-threatening reactions can be de-labeled using a risk stratification protocol developed to guide skin testing and challenge tests.</s><s>Compliance with recommendations for de-labeling can be increased by improved communication with patients and their physicians <ref type="bibr" target="#b141">[142]</ref>.</s></p><p><s>In 72 patients without HIV who had a history of sulfonamide adverse drug reactions, the outcomes of trimethoprim-sulfamethoxazole desensitization were evaluated for safety and efficacy after graded administration using short protocols (90 minutes to six hours), one-day protocols, or longer protocols.</s><s>Desensitization was discontinued due to adverse reactions in only eight patients <ref type="bibr" target="#b142">[143]</ref>.</s></p><p><s>Paracetamol, a weak COX inhibitor, rarely triggers symptoms in patients with non-selective hypersensitivity reactions to NSAIDs.</s><s>Use of a provocation test with paracetamol in children with a history of NSAID allergy is reported to exclude paracetamol as an inducer of anaphylaxis and identify it as a safe treatment option <ref type="bibr" target="#b143">[144]</ref>.</s></p><p><s>A retrospective study supports a comprehensive evaluation and management plan for patients with hypersensitivity reactions during anesthesia.</s><s>Of 72 such patients referred to allergy/immunology, 18 % had positive skin tests to beta-lactam antibiotics, neuromuscular blockers, latex, or other agents.</s><s>One patient who had an elevated basal tryptase level was diagnosed with mastocytosis.</s><s>On follow-up, 96 % of the 47 patients requiring subsequent anesthesia tolerated it uneventfully.</s><s>The two patients with recurrent reactions were later diagnosed with mast cell disorders <ref type="bibr" target="#b144">[145]</ref>.</s></p><p><s>IgA-deficient individuals with anti-IgA antibodies can develop anaphylaxis during transfusion of blood or blood products.</s><s>As compared with time-consuming quantitative assays such as the fluorescein enzyme immunoassay, rapid non-quantitative DiaMed particle gel immunoassays for identifying IgA-deficiency and antibodies to IgA have reasonable sensitivity and specificity.</s><s>They are potentially useful in emergency situations for diagnosing anti-IgA-related anaphylaxis and identifying donors who can provide IgA-deficient blood products <ref type="bibr" target="#b145">[146]</ref>.</s></p><p><s>Use of first-line chemotherapy and monoclonal agents for malignancies and chronic inflammatory diseases prolongs patient survival and minimizes morbidity.</s><s>Desensitization should be considered when patients develop drug hypersensitivity to first-line agents and no alternative therapies are available, or when alternative treatments are considered to be therapeutically inferior and/or more toxic.</s><s>The indications, protocols, and outcomes of desensitizations for chemotherapy and monoclonal antibodies in adults and children have been reviewed <ref type="bibr" target="#b146">[147]</ref>.</s></p><p><s>Influenza vaccine should not be withheld from eggsensitized patients, even those with a history of egginduced anaphylaxis <ref type="bibr" target="#b147">[148]</ref>.</s><s>The egg content of 2015 influenza vaccines is below the threshold needed to trigger reactions in egg-sensitized people.</s><s>Injected and intranasal influenza vaccines have been studied in 4315 patients with egg allergy, including 656 patients with a history of anaphylaxis to ingested egg.</s><s>The rare patients with a history of urticaria or anaphylaxis after immunization with influenza vaccine need an allergy/ immunology evaluation that includes skin tests to the vaccine itself <ref type="bibr" target="#b147">[148]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Idiopathic anaphylaxis</head><p><s>In idiopathic anaphylaxis, by definition, meticulous history, skin tests and measurement of allergen-specific IgE levels have not revealed the trigger.</s><s>In 20 % of 110 patients with previously diagnosed idiopathic anaphylaxis, the etiology of the episode was identified by testing with the ImmunoCAP ISAC 103 allergen array in addition to the ImmunoCAP 250 platform.</s><s>Omega-5 gliadin and shrimp accounted for 45 % of the previously unrecognized sensitizations.</s><s>Clinical reassessment substantiated the etiologic link in many patients <ref type="bibr" target="#b148">[149]</ref>.</s></p><p><s>In idiopathic anaphylaxis, there are no RCTs of interventions and no standardized treatment recommendations.</s><s>Rituximab infusions induced remission of idiopathic anaphylaxis in a patient who had anaphylaxis symptoms every 3-30 days despite prophylaxis with high-dose H 1and H 2 -antihistamines, a leukotriene antagonist, systemic glucocorticoids, mycophenolate mofetil, omalizumab, and a diet restricted to three foods <ref type="bibr" target="#b149">[150]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>The recommendations for the assessment, management and prevention of anaphylaxis promulgated in the 2011 WAO Anaphylaxis Guidelines are supported and strengthened year-on-year by publication of new, relevant, epidemiological and experimental research findings, including some RCTs.</s></p><p><s>Important advances in 2014-2015 comprised further elucidation of patient risk factors and co-factors that amplify anaphylaxis, and greater insights into anaphylaxis triggers such as food, venom, and drugs, as well as idiopathic anaphylaxis.</s><s>A prospective study documented the genomic basis of anaphylaxis and the cascade of mediators released during innate immune system activation in the first three hours after symptom onset.</s></p><p><s>High-quality observational studies published in 2014-2015 have confirmed that prompt injection of epinephrine reduces hospital admissions and that IM epinephrine injections are 10-fold safer than IV bolus injections.</s><s>A study of anaphylaxis fatalities found that 23 % of those who died did not receive epinephrine until cardiac arrest.</s><s>New developments in long-term management of anaphylaxis include novel EAIs, prospective studies of anaphylaxis education, and substantial progress in use of immunomodulation to prevent anaphylactic episodes.</s></p></div>		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We acknowledge the support of WAO President, Dr. Lanny J. Rosenwasser, and the WAO Board of Directors.</s><s>We also sincerely thank Lori McNiven, Health Sciences Centre, Winnipeg, MB, Canada for expert assistance.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Abbreviations ACE: Angiotensin-converting enzyme; Alpha-gal: Galactose-alpha Authors' contributions FERS reviewed the anaphylaxis research published in peer-reviewed indexed journals from January 2014 through mid-year 2015, led the development of the 2015 Update, and prepared the initial, interim, and final drafts of the manuscript.</s><s>ME was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>MSB was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>BYT was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>MW was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>LKT was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>RFL was involved in the selection of studies for inclusion in this manuscript and commented critically on drafts of the manuscript.</s><s>YEG was involved in the selection of studies for inclusion in this manuscript.</s><s>SGAB was involved in the selection of studies for inclusion in this manuscript.</s><s>HSP was involved in the selection of studies for inclusion in this manuscript.</s><s>AS was involved in the selection of studies for inclusion in this Update and commented critically on drafts of the manuscript.</s><s>All authors are members of the WAO Anaphylaxis Committee, 2014-2015.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Submit your next manuscript to</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">for the World Allergy Organization. World Allergy Organization guidelines for the assessment and management of anaphylaxis</title>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lrf</forename><surname>Ardusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Bilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>El-Gamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Ledford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="587" to="593" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Update: World Allergy Organization (WAO) guidelines for the assessment and management of anaphylaxis</title>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lrf</forename><surname>Ardusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Bilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dimov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ebisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>El-Gamal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="389" to="399" />
			<date type="published" when="2012">2012. 2012</date>
		</imprint>
	</monogr>
	<note>for the World Allergy Organization</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">for the World Allergy Organization. World Allergy Organization anaphylaxis guidelines: 2013 update of the evidence base</title>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lrf</forename><surname>Ardusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dimov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ebisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>El-Gamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Lockey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="193" to="204" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">International consensus on (ICON) anaphylaxis</title>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lrf</forename><surname>Ardusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Bilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cardona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ebisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>El-Gamal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">WAO J</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">9</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Bilò</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brockow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fernández</forename><surname>Rivas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1026" to="1045" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Anaphylaxis -a practice parameter update</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Nicklas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Randolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Oppenheimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bernstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Epidemiology of anaphylaxis</title>
		<author>
			<persName><forename type="first">Tejedor</forename><surname>Alonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Moro</forename><surname>Moro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Múgica</forename><surname>García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1027" to="1039" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Camargo</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Lieberman</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Zitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="461" to="467" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Trends in hospitalizations for foodinduced anaphylaxis in US children</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rudders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Arias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Camargo</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="960" to="962" />
			<date type="published" when="2000">2000-2009. 2014</date>
		</imprint>
	</monogr>
	<note>e3</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: an analysis of the Italian Ministry of Health database</title>
		<author>
			<persName><forename type="first">R</forename><surname>Nocerino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cosenza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Canani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="833" to="835" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e3</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Time trends in Australian hospital anaphylaxis admissions in 1998</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mullins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kbg</forename><surname>Dear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mlk</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="367" to="375" />
			<date type="published" when="1999">1999 to 2011-2012. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Gowland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ierodiakonou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Harper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Garcez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="956" to="963" />
			<date type="published" when="1992">1992-2012. 2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Case fatality and population mortality associated with anaphylaxis in the United States</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Danoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Borish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1075" to="1083" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Fatal anaphylaxis in the United States, 1999-2010: Temporal patterns and demographic associations</title>
		<author>
			<persName><forename type="first">E</forename><surname>Jerschow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Scaperotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Mcginn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1318" to="1328" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e7</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Categorization of allergic disorders in the new World Health Organization International Classification of Diseases</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Tanno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Calderon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Papadopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Demoly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Transl Allergy</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">42</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Constructing a classification of hypersensitivity/allergic diseases for ICD-11 by crowdsourcing the allergist community</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Tanno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Calderon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gayraud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Bircher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Casale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="609" to="615" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals</title>
		<author>
			<persName><forename type="first">S</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rudders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Camargo</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1125" to="1130" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">for the KAAACI Work Group on Urticaria/Angioedema/Anaphylaxis. Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Sohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">I</forename><surname>Koh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy Asthma Immunol Res</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="22" to="29" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years)</title>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1125" to="1131" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vazquez-Ortiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alvaro</forename><forename type="middle">M</forename><surname>Piquer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Giner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Dominguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Lozano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="482" to="484" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Management of hypersensitivity reactions to anti-D immunoglobulin preparations</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rutkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Nasser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1560" to="1563" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Anaphylaxis and cardiovascular diseases: a dangerous liaison</title>
		<author>
			<persName><forename type="first">M</forename><surname>Triggiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Montagni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ridolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="309" to="315" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Anaphylaxis and cardiovascular disease: therapeutic dilemmas</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1288" to="1295" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Predictors of clinical effectiveness of Hymenoptera venom immunotherapy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rueff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oude</forename><surname>Elberink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chatelain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dugas-Breit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="736" to="746" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Angiotensinconverting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase</title>
		<author>
			<persName><forename type="first">J</forename><surname>Stoevesandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Stolze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kerstan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trautmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="747" to="755" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nassiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dölle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Edenharter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ruëff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="491" to="499" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders</title>
		<author>
			<persName><forename type="first">P</forename><surname>Valent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="914" to="920" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The presence of mast cell clonality in patients with unexplained anaphylaxis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Gulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hagglund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dahlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nilsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1179" to="1187" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM</title>
		<author>
			<persName><forename type="first">I</forename><surname>Alvarez-Twose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zanotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gonzalez-De-Olano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bonadonna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Matito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="520" to="528" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Recognizing mastocytosis in patients with anaphylaxis: Value of KIT D816V mutation analysis of peripheral blood</title>
		<author>
			<persName><forename type="first">S</forename><surname>Broesby-Olsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Oropeza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bindslev-Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vestergaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Møller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Siebenhaar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="262" to="264" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Clinical characteristics and risk profile of patients with elevated baseline serum tryptase</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hemmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wohrl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sesztak-Greinecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jarisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wantke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergol Immunopathol (Madr)</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="544" to="552" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Basal platelet-activating factor acetylhydrolase: Prognostic marker of severe Hymenoptera venom anaphylaxis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Pravettoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piantanida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Primavesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Forti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Pastorello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1218" to="1220" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>O'brien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1471" to="1474" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Galactosealpha-1,3-galactose sensitization is a prerequisite for pork-kidney allergy and cofactor-related mammalian meat anaphylaxis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hebsaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Caponetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Platts-Mills</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Biedermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="755" to="759" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Pathophysiological mechanisms of exercise-induced anaphylaxis: an EAACI position statement</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ansley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bonini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Giacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Du</forename><surname>Toit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Khaitov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="1212" to="1221" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Brockow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kneissl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Zelger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grosber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kugler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="977" to="984" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e4</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Estrogen increases the severity of anaphylaxis in female mice through enhanced endothelial nitric oxide synthase expression and nitric oxide production</title>
		<author>
			<persName><forename type="first">V</forename><surname>Hox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Desai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bandara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gilfillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Metcalfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Olivera</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="729" to="736" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e5</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">First European data from the network of severe allergic reactions (NORA)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moneret-Vautrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fernandez-Rivas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cardona</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1397" to="1404" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Food allergy: epidemiology, pathogenesis, diagnosis, and treatment</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Sicherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="291" to="307" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Food allergy: a practice parameter update -2014</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aceves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1016" to="1025" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e43</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Umasunthar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leonardi-Bee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hodes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Warner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1621" to="1636" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Prevalence and characteristics of adult-onset food allergy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Kamdar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Saltoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bryce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="114" to="115" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Recurrent reactions to food among children at paediatric emergency departments: epidemiology of allergic disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vetander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Ly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hakansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lilja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nilsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ostblom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="113" to="120" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Systematic review on cashew nut allergy</title>
		<author>
			<persName><forename type="first">Jpm</forename><surname>Van Der Valk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aej</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gerth Van Wijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Wichers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>De Jong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="692" to="698" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Commins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Pochan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Land</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>King</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="108" to="115" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Oral mite anaphylaxis caused by mite-contaminated okonomiyaki/pancake-mix in Japan: 8 case reports and a review of 28 reported cases</title>
		<author>
			<persName><forename type="first">K</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukutomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sekiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Watai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mitsui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergol Int</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="51" to="56" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Potential food allergens in medications</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kelso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1509" to="1518" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Hypersensitivity to methylprednisolone sodium succinate in children with milk allergy</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nahum</forename><forename type="middle">A</forename><surname>Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Garty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Z</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="471" to="474" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Casein-related anaphylaxis after use of an Everlast kickboxing glove</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Scheer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gruchalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Adkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="269" to="271" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">New directions in diagnostic evaluation of insect allergy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Golden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="334" to="339" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Hymenoptera-sting hypersensitivity</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Casale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Burks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="page" from="1432" to="1439" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Sturm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kranzelbinder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Sturm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bokanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vollmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1635" to="1643" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergens</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cifuentes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vosseler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Seismann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Darsow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bredehorst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="909" to="910" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Component resolution reveals additional major allergens in patients with honeybee venom allergy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bantleon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huss-Marp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1383" to="1389" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e6</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Retrospective study of drug-induced anaphylaxis treated in the emergency department or hospital: patient characteristics, management, and 1-year follow-up</title>
		<author>
			<persName><forename type="first">A</forename><surname>Banerji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rudders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Camargo</forename><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="46" to="51" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Multinational experience with hypersensitivity drug reactions in Latin America</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Jares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sánchez-Borges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cardona-Villa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Ensina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arias-Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gómez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="282" to="289" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">International consensus on drug allergy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Demoly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Adkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brockow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Castells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Chiriac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Greenberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="420" to="437" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Health care use and serious infection prevalence associated with penicillin &quot;allergy&quot; in hospitalized patients: A cohort study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Macy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Contreras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="790" to="796" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of &quot;penicillin allergy&quot; in a UK teaching hospital</title>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Krishna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Razaq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pillay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1088" to="1092" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="439" to="444" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Macy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Contreras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="745" to="752" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gaeta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Valluzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alonzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maggioletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Caruso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Romano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="972" to="976" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Moxifloxacin hypersensitivity: uselessness of skin testing</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Uyttebroek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Sabato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Bridts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Clerck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Ebo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="443" to="445" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Azithromycin anaphylaxis in children</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pecorari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pantano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Rossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Martino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Immunopathol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="121" to="126" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Aun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Blanca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Garro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kalil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Motta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="414" to="420" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Drug-induced anaphylaxis survey in Portuguese allergy departments</title>
		<author>
			<persName><forename type="first">E</forename><surname>Faria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rodrigues-Cernadas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gaspar</forename><forename type="middle">A</forename><surname>Botelho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lopes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Investig Allergol Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="40" to="48" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Anaphylaxis to diclofenac: nine cases reported to the Allergy Vigilance Network in France</title>
		<author>
			<persName><forename type="first">J</forename><surname>Picaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Beaudouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Renaudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pirson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Metz-Favre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dron-Gonzalvez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1420" to="1423" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Craig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Riedl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Lumry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Macginnitie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="206" to="212" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Hypersensitivity to biological agents -updated diagnosis, management, and treatment</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Galvao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Castells</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="175" to="185" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Incidence of suspected perioperative anaphylaxis: A multicenter snapshot study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Savic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kaura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yusaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Hammond-Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Howell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin ImmunolPract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="454" to="455" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reitter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Petitpain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Latarche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cottin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Massy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Demoly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="954" to="959" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Hypersensitivity associated with sugammadex administration: a systematic review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tsur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kalansky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1251" to="1257" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Standardized testing with chlorhexidine in perioperative allergy -a large single-centre evaluation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Opstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Malling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kroigaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mosbech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Skov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Poulsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1390" to="1396" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Evaluation of a prospectively administered written questionnaire to reduce the incidence of suspected latex anaphylaxis during elective cesarean delivery</title>
		<author>
			<persName><forename type="first">L</forename><surname>Péer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Brezis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shalit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Carvalho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Seri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Obstet Anesth</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="335" to="340" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e100154</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration&apos;s adverse event reporting system and review of case reports in the literature</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Raisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arabyat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Saf</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="15" to="23" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Anaphylaxis caused by intravenous fluorescein: clinical characteristics and review of literature</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Sohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intern Emerg Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="325" to="330" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Emergency department diagnosis and treatment of anaphylaxis: a practice parameter</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Nicklas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Sadosty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="599" to="608" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">International survey of knowledge of food-induced anaphylaxis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nowak-Węgrzyn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="644" to="650" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Does anaphylaxis masquerade as asthma in children</title>
		<author>
			<persName><forename type="first">N</forename><surname>Sargant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Erlewyn-Lajeunesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Benger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Med J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="83" to="84" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Case 2-2015: a 25-year-old man with abdominal pain, syncope, and hypotension</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Murali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Uyeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tingpej</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="265" to="273" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Idiopathic systemic capillary leak syndrome in children</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Frith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kakakios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Stone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="e730" to="735" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Caustic ingestions mimicking anaphylaxis: case studies and literature review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Sherenian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Clee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Schondelmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De Alarcon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Assa'ad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="e547" to="e550" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Correct recognition and management of anaphylaxis: not much change over a decade</title>
		<author>
			<persName><forename type="first">B</forename><surname>Plumb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gompels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Unsworth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Postgrad Med J</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="3" to="7" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">The utility of serum tryptase in the diagnosis of food-induced anaphylaxis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wongkaewpothong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pacharn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sripramong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boonchoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Piboonpocanun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Visitsunthorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy Asthma Immunol Res</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="304" to="309" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia</title>
		<author>
			<persName><forename type="first">D</forename><surname>Laroche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gomis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gallimidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Malinovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Mertes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="272" to="279" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Krishna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>York</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gnanakumaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heslegrave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Derbridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="399" to="404" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mclean-Tooke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goulding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bundell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hollingsworth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="134" to="138" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Plasma contact system activation drives anaphylaxis in severe mast cellmediated allergic reactions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sala-Cunill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bjorkqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guilarte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cardona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Labrador</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1031" to="1043" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e6</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networks</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bosco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Cotterell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Van Eeden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arendts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e101409</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Management of anaphylaxis: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dhami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Panesar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Worm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Bilò</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="168" to="175" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Early treatment of foodinduced anaphylaxis with epinephrine is associated with a lower risk of hospitalization</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Camargo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Rudders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="57" to="62" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Anaphylaxis-related deaths in Ontario: a retrospective review of cases from</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kastner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Harada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Salter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Waserman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy Asthma Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">38</biblScope>
			<date type="published" when="1986">1986 to 2011. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Acute allergic reactions in the emergency department: characteristics and management practices</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hitti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zaitoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Harmouche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saliba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mufarrij</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="253" to="259" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">A multifaceted intervention for patients with anaphylaxis increases epinephrine use in adult emergency department</title>
		<author>
			<persName><forename type="first">V</forename><surname>Manivannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Bellamkonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Nestler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Bellolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hagan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="294" to="299" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Rate, triggers, severity and management of anaphylaxis in adults treated in a Canadian emergency department</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Asai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yanishevsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">La</forename><surname>Vieille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Delaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Alizadehfar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="246" to="252" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Pre-hospital management of anaphylaxis in one Canadian urban centre</title>
		<author>
			<persName><forename type="first">T</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gaudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vandenberghe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Couperthwaite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sookram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Resuscitation</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1077" to="1082" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Epinephrine use and outcomes in anaphylaxis patients transported by emergency medical services</title>
		<author>
			<persName><forename type="first">V</forename><surname>Manivannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hyde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Hankins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Bellolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Fedko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Decker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1097" to="1102" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Bellolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Knutson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Bellamkonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Fedko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Nestler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="76" to="80" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">H 2 -antihistamines for the treatment of anaphylaxis with and without shock: a systematic review</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Nurmatov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rhatigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="126" to="131" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Bellolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Erwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Murad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="408" to="416" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">A review of methylene blue treatment for cardiovascular collapse</title>
		<author>
			<persName><forename type="first">Jcy</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Darracq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="670" to="679" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Cardiac arrest with anaphylactic shock: a successful resuscitation using extracorporeal membrane oxygenation</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="130" to="e133" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Outcomes of allergy/ immunology follow-up after an emergency department evaluation for anaphylaxis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kueber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hagan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="88" to="93" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Anaphylaxis in America: a national physician survey</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Camargo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Schwartz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="830" to="833" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Asawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Ghazi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="74" to="76" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Drug-device combination products in the 21 st century: development using a human factors engineering approach</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>North</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Drug Deliv</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="751" to="762" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Patients&apos; ability to treat anaphylaxis using adrenaline auto-injectors: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Umasunthar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Procktor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hodes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Cox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="855" to="863" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice</title>
		<author>
			<persName><forename type="first">O</forename><surname>Rachid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Wein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rawas-Qalaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Simons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="354" to="356" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Epinephrine autoinjectors: does freezing or refrigeration affect epinephrine dose delivery and enantiomeric purity?</title>
		<author>
			<persName><forename type="first">O</forename><surname>Rachid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fer</forename><surname>Simons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rawas-Qalaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Simons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="294" to="296" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">When should we perform a repeat training on adrenaline auto-injector use for physician trainees?</title>
		<author>
			<persName><forename type="first">E</forename><surname>Topal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bakirtas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Yilmaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ihe</forename><surname>Karagol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Demirsoy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergol Immunopathol (Madr)</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="472" to="475" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Brockow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schallmayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Biedermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="227" to="235" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>including the working group on anaphylaxis training education (AGATE)</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Long-term effectiveness of online anaphylaxis education for pharmacists</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Salter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Sanfilippo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Loh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Clifford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pharm Educ</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page">136</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">The development and implementation of the Chicago public schools emergency EpiPen policy</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Zadikoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Whyte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Desantiago-Cardenas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Harvey-Gintoft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gupta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Sch Health</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="342" to="347" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Design and validation of pictograms in a pediatric anaphylaxis action plan</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vaillancourt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Irwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zemek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Alqurashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="223" to="233" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">The evaluation of a food allergy and epinephrine autoinjector training program for personnel who care for children in schools and community settings</title>
		<author>
			<persName><forename type="first">A</forename><surname>Wahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruffo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Sch Nurs</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="91" to="98" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Low preparedness for food allergy as perceived by school staff: a EuroPrevall survey across Europe</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kummeling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Tolosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ballmer-Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Clausen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="480" to="482" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1046" to="1057" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Clinical management of food allergy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Perry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Newhall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="300" to="305" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">The predictive relationship between peanut-and Ara h2-specific serum IgE concentrations and peanut allergy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ebisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Moverare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Borres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="131" to="132" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e1</note>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Douiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bécares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Radulovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="645" to="652" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Skin testing with raw egg does not predict tolerance to baked egg in egg-allergic children</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Fox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="657" to="661" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Baked milk-and egg-containing diet in the management of milk and egg allergy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Caubet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Groetch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nowak-Wegrzyn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="13" to="23" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Safety and clinical predictors of reacting to extensively heated cow&apos;s milk challenge in cow&apos;s milk-allergic children</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Campbell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="425" to="429" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Adherence to extensively heated egg and cow&apos;s milk after successful oral food challenge</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mehr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Campbell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="125" to="127" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>e4</note>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Oral food challenge and food allergy quality of life in caregivers of children with food allergy</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Franxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Howe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Teich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Greenhawt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="50" to="56" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Growth comparison in children with and without food allergies in 2 different demographic populations</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ramesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Feuille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Groetch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="842" to="848" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents</title>
		<author>
			<persName><forename type="first">Jlp</forename><surname>Protudjer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Jansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Arnlind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kallstrom-Bengtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Marklund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="68" to="75" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Vickery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Scurlock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kamilaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Berglund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="468" to="475" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>e6</note>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Burks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Sicherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Fleischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Scurlock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1240" to="1248" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Oral immunotherapy in cow&apos;s milk allergic patients: course and long-term outcome according to asthma status</title>
		<author>
			<persName><forename type="first">A</forename><surname>Elizur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Nachshon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Katz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="240" to="244" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Burton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Logsdon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Medina-Tamayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abdel</forename><forename type="middle">-</forename><surname>Gadir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rivas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="1310" to="1317" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Randomized trial of peanut consumption in infants at risk for peanut allergy</title>
		<author>
			<persName><forename type="first">Du</forename><surname>Toit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Bahnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Radulovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="803" to="813" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">When can immunotherapy for insect sting allergy be stopped?</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="324" to="328" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting</title>
		<author>
			<persName><forename type="first">K</forename><surname>Palgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Bartuzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gotz-Zbikowska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Immunopathol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="109" to="112" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">The HIT study: Hymenoptera Identification Test -how accurate are people at identifying stinging insects?</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Forester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stolfi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Stahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="267" to="270" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Koschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hoffken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Balck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Investig Allergol Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="226" to="230" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Ant venom immunotherapy in Australia: the unmet need</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Mullins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sga</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="33" to="34" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Anaphylaxis during skin prick testing for amoxicillin allergy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Syrigou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Syrigos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="478" to="479" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Patients with positive skin test results to penicillin should not undergo penicillin or amoxicillin challenge</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Solensky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Castells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Macy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="816" to="817" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Improving the effectiveness of penicillin allergy de-labeling</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bourke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pavlos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Phillips</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="365" to="374" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Successful outpatient graded administration of trimethoprimsulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Pyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Butterfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Volcheck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Podjasek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Rank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jtc</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="52" to="58" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Drug-induced anaphylaxis in children: Nonsteroidal anti-inflammatory drugs and drug provocation test</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Ensina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>De Lacerda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>De Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Camelo-Nunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Solé</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">825</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Guyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Saff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Conroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Blumenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Camargo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Long</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="94" to="100" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Detection of anti-IgA antibodies using the particle gel immunoassay: a rapid test for increased patient safety</title>
		<author>
			<persName><forename type="first">S</forename><surname>Oltean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Epure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lindstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Transfus</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="334" to="339" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Dioun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="13" to="19" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Influenza vaccine and egg allergy: nearing the end of an evidence-based journey</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kelso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="140" to="141" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Heaps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Selwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moody</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Unsworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Deacock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="483" to="490" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Induction of remission of idiopathic anaphylaxis with rituximab</title>
		<author>
			<persName><forename type="first">A</forename><surname>Borzutzky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Morales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mezzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nussbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Burks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="981" to="983" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
